Latest Headlines
-
GENiSYS® C Flexible Small-Batch Isolated Filling System Available For 6-Month Delivery
1/10/2025
Available for quick delivery, AST's Isolated GENiSYS® C is a fully integrated solution for the production of high-value liquid pharmaceuticals. Designed in collaboration with Germfree, and leveraging the latest American-made turnkey technology from AST, this production system is backed by a localized, responsive model for supply and service.
-
INTERPHEX Announces Show Floor Tour Options In Partnership With Parenteral Drug Association And CRB Group
1/9/2025
INTERPHEX is excited to announce a new initiative to create dynamic and interactive opportunities for a broader range of attendees. Based on valuable insights from customer surveys and the INTERPHEX Attendee Advisory Committee, we are introducing reimagined Show Floor Tour options that focus on diverse industry themes. These tours are designed to maximize attendee engagement and ensure more meaningful exploration of the show floor. To bring these ideas together, INTERPHEX has partnered with CRB Group and PDA for their industry expertise.
-
CRB Announces Exhibition And Speaker Schedule For Advanced Therapies Week 2025
1/9/2025
Attending the show? Make sure to meet CRB’s team of cell and gene therapy specialists at Advanced Therapies Week in booth 566. CRB’s subject matter expert, Peter Walters, will be presenting an educational seminar in the session “Developing Future Facilities While Supporting the Advanced Therapies Ecosystem."
-
IPS Enhances Innovation With Three Expert Process Architects
12/27/2024
IPS proudly welcomes April Chen, AIA, LEED AP, Paul Szafir, AIA, LEED AP, and Nevine William, AIA, LEED AP, to its Global Strategy & Technology (GS&T) Group. These strategic hires reinforce IPS’ commitment to providing clients with expert guidance in designing advanced facilities that balance technical excellence with operational, regulatory, and business success. All three hires bring extensive experience in designing and managing facilities that produce cutting-edge therapies such as mRNA vaccines, CAR-T cell therapies, and gene editing technologies.
-
AES Clean Technology Names Former CRB Executive To Drive Western Region Growth
12/20/2024
AES Clean Technology, a leading provider of high-performance cleanroom facilities, has today announced the appointment of Jeff Rozelle as Senior Vice President of Business Development, West Region.
- Comparing Lab Equipment Options: New vs. Refurbished 12/13/2024
-
Germfree Launches Smarthood™: A Groundbreaking, Software-Agnostic IV Workflow Solution Transforming Sterile Compounding
12/9/2024
Smarthood™ is the first solution to integrate IV workflow software, hardware, and peripherals directly into the hood enhancing best practices, bolstering safety, and streamlining the entire workflow.
-
ROSS VersaMix Multi Shaft Mixers For Complex Formulations
11/26/2024
The ROSS VersaMix VMC-320 is a versatile multi-shaft mixer for processing viscous solutions, offering powerful agitators, customizable controls, and semi-continuous operation with robust safety features.
-
CDMO Hovione Expands Global Spray Drying Capacity With Significant Investment In USA And Ireland
11/25/2024
Hovione expands spray drying capacity in New Jersey and Cork, enhancing capabilities for drug solubility and bioavailability, creating jobs, and reinforcing its leadership in pharma manufacturing.
-
PCI Pharma Services And ChiRhoClin Partner To Prevent Shortage Of Critical Orphan Pancreatic Drug
11/19/2024
PCI Pharma Services – (“PCI”) a leading global contract development and manufacturing organization (CDMO) focused on biopharma’s most complex therapies – is collaborating with theranostics specialist ChiRhoClin, Inc. to avoid the potential shortage of a critical diagnostic drug used to test for pancreatic disease and cancer. Following a high-priority